GlassScriptPhysician profile
Micah D Buckel
NPI 1902200413
$7,064.51
in general payments reported to CMS, 2019-2025
37 companies · $1,426 in 2025
The $1,426 reported for 2025 was more than what 86% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,180 · 2022: $1,137 · 2023: $1,461 · 2024: $1,860 · 2025: $1,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,734 · Education: $12.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,734.41 |
| Education | $12.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,074.48 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $986.20 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $756.07 | 2021-2025 | |
| Abbvie INC. | $541.07 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $510.82 | 2021-2025 | Airsupra, Farxiga, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $457.54 | 2021-2024 | Jardiance, Spiriva Respimat, Ofev |
| Merck Sharp & Dohme LLC | $335.86 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Esperion Therapeutics, INC. | $318.29 | 2021-2023 | Nexletol |
| Exact Sciences Corporation | $215.49 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Antares Pharma, INC. | $193.14 | 2021-2025 | Xyosted |
| Sanofi-Aventis U.S. LLC | $191.54 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $163.09 | 2023-2024 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $142.88 | 2022 | |
| Abbott Laboratories | $111.64 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Gilead Sciences, INC. | $95.16 | 2024-2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Buckel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.